Kirby Daniel Gordon 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Kirby Daniel Gordon
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2025-06-05$1.84/sh+30,000$55,200→ 30,000 total
Footnotes (1)
- [F1]Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.